Oculis Holding AG

NasdaqGM:OCS Stock Report

Market Cap: US$713.1m

Oculis Holding Management

Management criteria checks 0/4

Oculis Holding's CEO is Riad Sherif, appointed in Dec 2017, has a tenure of 7.08 years. directly owns 2.26% of the company’s shares, worth $16.11M. The average tenure of the management team and the board of directors is 0.9 years and 2.2 years respectively.

Key information

Riad Sherif

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure7.1yrs
CEO ownership2.3%
Management average tenureless than a year
Board average tenure2.2yrs

Recent management updates

Recent updates

Oculis: Lack Of Coverage Only Real Risk For This Solid Company

Nov 04

CEO

Riad Sherif (56 yo)

7.1yrs

Tenure

Dr. Riad Sherif, MD, MBA, has been the Chief Executive Officer and Director of Oculis Holding AG (formerly known as Oculis SA) since December 2017. He is Chief Executive Officer and Director of Oculis ehf....

Leadership Team

NamePositionTenureCompensationOwnership
Riad Sherif
CEO & Director7.1yrsno data2.26%
$ 16.1m
Sylvia Cheung
Chief Financial Officer4.3yrsno data0.17%
$ 1.2m
Gudrun Bachmann
Chief Technology Officerless than a yearno datano data
Ramin Tadayoni
Chief Scientific Officerless than a yearno datano data
Daniel Char
Chief Legal Officerless than a yearno datano data
Virginia Dean
Chief Human Resources Officerless than a yearno datano data
Páll Jóhannesson
Chief Business Officer4.3yrsno data0.59%
$ 4.2m
Rebecca Weil
Chief Commercial Officer1.3yrsno datano data
Snehal Shah
President of Research & Developmentless than a yearno datano data
Sharon Klier
Chief Development Officerless than a yearno datano data
Isabelle de Chambrier
Senior Vice President of Quality1.3yrsno datano data

0.9yrs

Average Tenure

56yo

Average Age

Experienced Management: OCS's management team is not considered experienced ( 0.9 years average tenure), which suggests a new team.

Board Members

NamePositionTenureCompensationOwnership
Riad Sherif
CEO & Director7.1yrsno data2.26%
$ 16.1m
Eric Donnenfeld
Chair of Cornea Scientific Advisory Boardno datano datano data
Anthony Rosenberg
Independent Chairman6.8yrsno data0.26%
$ 1.8m
Christophe Baudouin
Member of Scientific Advisory Board2.2yrsno datano data
Peter Kaiser
Member of Scientific Advisory Board2.2yrsno datano data
Lionel Carnot
Independent Director7.1yrsno datano data
Christina Ackermann
Independent Director1.8yrsno data0.028%
$ 199.2k
Quan Dong Nguyen
Member of Scientific Advisory Board2.2yrsno datano data
Robert Warner
Directorless than a yearno datano data
Arshad Khanani
Chair of Retina Scientific Advisory Board & Director2.2yrsno datano data
Anat Loewenstein
Member of Scientific Advisory Board2.2yrsno datano data
Pablo Villoslada
Member of Scientific Advisory Board2.2yrsno datano data

2.2yrs

Average Tenure

59yo

Average Age

Experienced Board: OCS's board of directors are not considered experienced ( 2.2 years average tenure), which suggests a new board.

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/02 14:25
End of Day Share Price 2025/01/02 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Oculis Holding AG is covered by 8 analysts. 7 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Colleen KusyBaird
Jason Matthew GerberryBofA Global Research
Daniil GataulinChardan Capital Markets, LLC